Puma Biotechnology | Despesas De Vendas E Administração

Selling And Administration Expenses Alterar Data
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Exelixis USD 138.14M 3.58M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
Incyte USD 293.86M 25.97M 2023-12
Moderna USD 470M 28M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
PTC Therapeutics USD 76.29M 4.6M 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Takeda JPY 252.95B 4.84B 2023-09
TG Therapeutics USD 31.15M 1.62M 2023-12
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Puma Biotechnology Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.